Menopause has long been associated with physical symptoms like hot flashes and night sweats, but emerging research highlights its profound impact on mental health. A study published in JAMA Psychiatry found that women undergoing perimenopause—the transitional phase leading up to menopause—are twice as likely to experience depression and anxiety compared to premenopausal women.
Hormonal fluctuations, particularly drops in estrogen, play a key role in these mood changes. Estrogen helps regulate serotonin and dopamine, neurotransmitters critical for emotional stability. When levels decline, women may face increased irritability, brain fog, and even panic attacks. Yet, mental health struggles during menopause are often overlooked or misattributed to aging.
Dr. Lucy Hutner, a reproductive psychiatrist and co-author of the study, stressed the need for greater awareness. “Too many women are told to ‘just push through’ menopause, but the psychological toll can be debilitating. We need to normalize conversations about this and provide better treatment options.”
Cognitive behavioral therapy (CBT) and hormone replacement therapy (HRT) have shown promise in alleviating symptoms, but access remains a barrier. A survey by the North American Menopause Society found that only 20% of women receive mental health support during menopause, partly due to stigma and a lack of provider training.
To address this gap, organizations like The Menopause Charity are launching campaigns to educate both women and healthcare providers. Digital platforms, such as telehealth services specializing in menopause care, are also expanding access to treatment.
As societal attitudes shift, experts hope menopause will be recognized as a critical window for mental health intervention. “This isn’t just about hot flashes—it’s about ensuring women can thrive during this phase of life,” said Dr. Hutner. “With the right support, menopause doesn’t have to be a struggle.”
You Might Be Interested In:
- Novel Alzheimer’s Therapy Shows Low Risk of Severe Side Effects, Real-World Data Confirms
- CAR-T Cell Therapy Linked to “Brain Fog” in Cancer Patients, Stanford Study Finds
- Testosterone Use Not Linked to Increased Gynecological Cancer Risk in Early Years
